The effector T cells of diabetic subjects are resistant to regulation via CD4+FOXP3+ regulatory T cells

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 7350-7355

  Schneider, Anya ^a   Rieck, Mary ^a   Sanda, Srinath ^a   Pihoker, Catherine ^b   Greenbaum, Carla ^a   Buckner, Jane H ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CD4+ CD25+ FOXP3+ REGULATORY T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; EFFECTOR CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; CELL PROLIFERATION; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

CELL PROLIFERATION; COCULTURE TECHNIQUES; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 58149188480     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.7350     Document Type: Article

References (24)

1. + T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop. Ann. NY Acad. Sci. 1079: 9-18.
2. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
3. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465. (Pubitemid 38780401)
4. Wildin, R. S., F. Ramsdell, J. Peake, F. Faravelli, J. L. Casanova, N. Buist, E. Levy-Lahad, M. Mazzella, O. Goulet, L. Perroni, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27: 18-20.
5. high regulatory T cells in human autoimmune diabetes. J. Autoimmun. 24: 55-62.
6. + regulatory T-cells in type 1 diabetes. Diabetes 56: 604-612.
7. + T-cells in type 1 diabetes. Diabetes 54: 1407-1414.
8. + T-cells from patients with type 1 diabetes. Diabetes 54: 92-99.
9. +. J. Clin. Invest. 112: 1437-1443.
10. + T cells. J. Autoimmun. 30: 293-302.
11. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
12. Clough, L. E., C. J. Wang, E. M. Schmidt, G. Booth, T. Z. Hou, G. A. Ryan, and L. S. Walker. 2008. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. J. Immunol. 180: 5393-5401.
13. Gregori, S., N. Giarratana, S. Smiroldo, and L. Adorini. 2003. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171: 4040-4047. (Pubitemid 37238678)
14. You, S., M. Belghith, S. Cobbold, M. A. Alyanakian, C. Gouarin, S. Barriot, C. Garcia, H. Waldmann, J. F. Bach, and L. Chatenoud. 2005. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54: 1415-1422. (Pubitemid 40586672)
15. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Backstrom, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431. (Pubitemid 46559831)
16. Yang, J., M. O. Brook, M. Carvalho-Gaspar, J. Zhang, H. E. Ramon, M. H. Sayegh, K. J. Wood, L. A. Turka, and N. D. Jones. 2007. Allograft rejection mediated by memory T cells is resistant to regulation. Proc. Natl. Acad. Sci. USA 104: 19954-19959.
17. +. Arthritis Rheum. 58: 2120-2130.
18. hi T-regulatory cells. Blood 108: 253-261.
19. + T cell suppressor function. J. Immunol. 172: 6519-6523.
20. +. J. Immunol. 175: 641-645.
21. + regulatory T cells in inflamed synovia. J. Exp. Med. 201: 1793-1803.
22. + T lymphocytes. J. Immunol. 178: 732-739.
23. Toscano, M. A., G. A. Bianco, J. M. Ilarregui, D. O. Croci, J. Correale, J. D. Hernandez, N. W. Zwirner, F. Poirier, E. M. Riley, L. G. Baum, and G. A. Rabinovich. 2007. Differential glycosylation of TH1, TH2, and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 8: 825-834.
24. Peakman, M., T. Warnock, A. Vats, G. L. McNab, J. Underhill, P. T. Donaldson, and D. Vergani. 1994. Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives. Diabetologia 37: 155-165. (Pubitemid 24042884)